Calyx
Perceptive (formerly Calyx) is a global clinical research services provider delivering medical imaging, preclinical imaging, IRT/RTSM, eCOA, and clinical intelligence solutions to biopharmaceutical sponsors and CROs across the US, Europe, and Asia.
- Company typePrivate
- Founded-
- HeadquartersIrvine, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What Calyx does
Calyx Services Inc., now operating under the unified brand Perceptive, is a privately held clinical research services organization headquartered in Irvine, California, with 1,001–5,000 employees and a delivery footprint across the US, Europe, and Asia. The company provides medical imaging, eClinical, and regulatory solutions to global biopharmaceutical sponsors and contract research organizations, organized into three sub-brands: Perceptive Discovery (preclinical imaging, radiochemistry, biodistribution, and in-house clinical/imaging centers), Perceptive eClinical (IRT/RTSM, eCOA, and clinical intelligence), and Perceptive Imaging (clinical imaging core lab services). The product portfolio includes the proprietary VivoQuant™ preclinical imaging analysis software alongside services spanning CNS, oncology, hematology, rare diseases, radiopharmaceutical therapy, and obesity indications.
Underlying technology comprises a clinical imaging core lab platform, a randomization and trial supply management (IRT/RTSM) system, an electronic clinical outcome assessment (eCOA) capability, and a Clinical Intelligence analytics layer. The business model combines per-trial professional services contracts with subscription and licensing revenue from IRT/RTSM and eClinical software, sold primarily through enterprise field sales directly to large pharma sponsors and CROs. The organization reports having supported 11,000+ trials and 800+ regulatory approvals cumulatively across 50+ years of combined experience.
In 2024, Calyx acquired Invicro from REALM IDx, Inc. and subsequently rebranded the combined entity as Perceptive, consolidating preclinical imaging, clinical trial imaging, and RTSM services under a single global brand. The company is led by CEO Gavin Nichols alongside a full operating C-suite covering commercial, medical, digital, legal, and people functions.
Calyx firmographics
Firmographics- Name
- Calyx
- Legal name
- Calyx Services Inc.
- Website
- https://calyx.ai
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Perceptive (formerly Calyx) is a global clinical research services provider delivering medical imaging, preclinical imaging, IRT/RTSM, eCOA, and clinical intelligence solutions to biopharmaceutical sponsors and CROs across the US, Europe, and Asia.
- Ownership category
- akta.pro rank
Calyx industry classification
Industry- Product category
- Clinical Trial Imaging & eClinical Services
- NAICS
- Medical Laboratories (621511), Scientific Research and Development Services (5417), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where Calyx is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Markets served
Calyx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Clinical Imaging Services: Provides imaging core lab services for clinical trials including medical imaging acquisition, reading, and analysis across multiple therapeutic areas. Services are contracted on a per-trial basis, typically as part of larger clinical development programs with pharmaceutical sponsors.
- IRT/RTSM Services: Randomization and Trial Supply Management services provided as SaaS or managed service for clinical trials. Revenue generated through licensing and service fees for the IRT/RTSM platform.
- Preclinical Imaging Services: Preclinical imaging services including in-house imaging centers, radiochemistry, biodistribution services, and radioligand binding assay services for early-stage drug discovery and development.
- eClinical Services: Electronic clinical outcome assessment (eCOA) and related eClinical services for clinical trials.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Calyx product offering
Product offeringCore offering
Calyx (now Perceptive) provides clinical trial medical imaging core lab services, preclinical imaging, randomization and trial supply management (IRT/RTSM), electronic clinical outcome assessments (eCOA), clinical intelligence analytics, radiochemistry, biodistribution, and radioligand binding assay services to pharmaceutical sponsors and CROs. Its proprietary VivoQuant™ software supports preclinical imaging analysis. Services are delivered through direct enterprise contracts and SaaS-style platform licensing to support drug development programs across CNS, oncology, hematology, rare diseases, obesity, and radiopharmaceutical therapy.
Product overview
Perceptive (formerly Calyx) operates as an integrated platform of clinical research services with three interconnected divisions: Discovery (preclinical imaging, radiochemistry, and in-house imaging centers), eClinical (IRT/RTSM, eCOA, and clinical intelligence), and Imaging (core lab services). The portfolio includes the VivoQuant™ software product for preclinical image analysis. With over 50 years of combined experience, the company supports 11,000+ trials and 800+ regulatory approvals across therapeutic areas including CNS, oncology, hematology, rare diseases, and radiopharmaceutical therapy.
Differentiator
Problem solved
Functional benefit
Brands
- Perceptive: Unified brand for preclinical imaging, clinical trial imaging, and randomization and trial supply management (RTSM) services
- Perceptive Discovery
- Perceptive eClinical
- Perceptive Imaging
Products and services
- Imaging Core Lab Centralized clinical trial imaging core laboratory providing standardized medical image acquisition, quality control, and analysis services for clinical studies, delivered to pharmaceutical sponsors and CROs.
- Preclinical Imaging Preclinical imaging services supporting drug discovery and development through in vivo imaging of animal models using multiple imaging modalities, targeted at pharmaceutical and biotech sponsors.
- IRT/RTSM Interactive Response Technology and Randomization and Trial Supply Management services for managing patient randomization, drug allocation, and supply chain logistics in clinical trials, delivered to pharmaceutical sponsors and CROs.
- VivoQuant™ Proprietary preclinical imaging analysis software for processing and analyzing in vivo imaging data from modalities including PET, SPECT, CT, and optical imaging, licensed to drug development teams.
- eCOA Electronic Clinical Outcome Assessment services enabling electronic capture of patient-reported, clinician-reported, and observer-reported outcomes in clinical trials, delivered to pharmaceutical sponsors and CROs.
- Clinical Intelligence Data analytics and insights platform providing clinical trial performance monitoring, operational metrics, and decision support capabilities across imaging and eClinical operations for sponsors.
- In-House Clinical and Imaging Centers Proprietary clinical and imaging center facilities enabling end-to-end study execution with integrated patient enrollment, imaging, and data collection capabilities for sponsor trials.
- Radiochemistry Radiopharmaceutical production and radiochemistry services supporting preclinical and clinical molecular imaging studies using PET and SPECT tracers for pharmaceutical and biotech sponsors.
- Biodistribution Services Quantitative analysis of radiopharmaceutical and drug distribution in tissues and organs for preclinical and clinical studies, supporting drug development programs in radiopharmaceutical therapy and theranostics.
- Radioligand Binding Assay Services Bioanalytical services for measuring radioligand binding and receptor occupancy in support of drug development programs, particularly for CNS, oncology, and rare disease therapeutics.
Quantifiable outcome
- 11,000+ trials implemented
- +2 more outcomes
Companies that use Calyx
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Calyx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Calyx partnerships and signals
Strategic signalScale indicators5 records
Recent moves8 records
Expansion highlights6 records
Calyx competitors and assessment
Company assessmentDirect peers
- Medpace: Medpace is a mid-to-large CRO focused on Phase II/III clinical development across multiple therapeutic areas. Comparable because it competes for the same biotech and pharma sponsors and increasingly offers imaging and eClinical capabilities.
- Parexel: Parexel is a global CRO offering Phase I–IV clinical development with therapeutic-area expertise. Comparable as a competing CRO serving the same enterprise pharma and biotech client base.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO focused on complex therapeutic areas including CNS, oncology, and rare diseases. Comparable as a direct competitor for the same specialty trial work that Perceptive supports.
- Clario: Clario is a clinical trial technology and imaging company offering eCOA, RTSM, and medical imaging core lab services. Highly comparable because it directly overlaps with Perceptive's eClinical and imaging core lab offerings.
- Charles River Laboratories: Charles River Laboratories provides preclinical and clinical research services, including preclinical imaging and CRO services. Comparable through its preclinical imaging and discovery services that overlap with Perceptive Discovery.
Broad incumbents
- ICON plc: ICON is a top-tier global CRO providing Phase I–IV clinical services, including imaging and eClinical solutions. Comparable as a direct competitor for large multi-regional clinical trials where Perceptive also competes.
- IQVIA: IQVIA is the largest global CRO offering full-service clinical development including imaging and RTSM. Comparable because it competes for the same pharmaceutical and biotech sponsors and can bundle Perceptive's core services into broader outsourcing contracts.
- Labcorp Drug Development (formerly Covance): Labcorp Drug Development is a global CRO with central laboratory, clinical development, and imaging-adjacent services. Comparable as a full-service competitor offering overlapping capabilities in clinical trial laboratory and eClinical services.
Emerging players
- WCG (WIRB-Copernicus Group): WCG provides clinical trial enablement services including site activation, IRB review, and trial technology. Comparable as an enabling peer in clinical research services that intersects with Perceptive's eClinical offerings.
- BioTel Research (formerly Biotelemetry/CardioNet): BioTel Research is a technology-enabled clinical research services provider focused on cardiac safety, imaging, and decentralized trials. Comparable as a specialized imaging and centralized diagnostic services peer overlapping with Perceptive Imaging.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Calyx social profiles
Digital presenceCalyx financial estimates
Financial estimateRevenue estimate
Valuation estimate
Calyx leadership team
Management profileNumber of profiles
Profiles8 records
Calyx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Calyx M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Calyx
What does Calyx do?
Calyx (now Perceptive) provides clinical trial medical imaging core lab services, preclinical imaging, randomization and trial supply management (IRT/RTSM), electronic clinical outcome assessments (eCOA), clinical intelligence analytics, radiochemistry, biodistribution, and radioligand binding assay services to pharmaceutical sponsors and CROs. Its proprietary VivoQuant™ software supports preclinical imaging analysis. Services are delivered through direct enterprise contracts and SaaS-style platform licensing to support drug development programs across CNS, oncology, hematology, rare diseases, obesity, and radiopharmaceutical therapy.
Is Calyx a public or private company?
Calyx is a private company. It is classified as unknown and is currently operating.
When was Calyx founded?
Calyx was founded in -1. It employs 1,001 to 5,000 people.
Where is Calyx based?
Calyx is headquartered in Irvine, United States, in the North America region.
How does Calyx make money?
Four revenue lines are on record. Clinical Imaging Services are the primary driver. The others are IRT/RTSM Services, preclinical Imaging Services and eClinical Services.
Who are Calyx's main competitors?
Direct peers on record are Medpace, Parexel, Worldwide Clinical Trials, Clario and Charles River Laboratories. Broad incumbents are ICON plc, IQVIA and Labcorp Drug Development (formerly Covance). Emerging players are WCG (WIRB-Copernicus Group) and BioTel Research (formerly Biotelemetry/CardioNet).
Does Calyx have an API?
No public API is recorded for Calyx.
What industry is Calyx in?
Calyx's product category is Clinical Trial Imaging & eClinical Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 621511 and its SIC code is 8071.